Home › NDC Lookup › RxCUI directory › RxCUI 311714

Heavy mineral oil 1000 MG/ML Oral Solution — RxCUI 311714

RxNorm drug concept · Semantic clinical drug
RxCUI 311714 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI311714
Official nameHeavy mineral oil 1000 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asheavy mineral oil 100 % Oral Solution
FDA products mapped2
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Heavy mineral oil 1000 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Heavy mineral oil 1000 MG/ML Oral Solution RxCUI 311714

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Heavy mineral oil 258439
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Heavy mineral oil Oral Solution 401639
    • Heavy mineral oil Oral Liquid Product 1160305
    • Heavy mineral oil Oral Product 1160306
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Heavy mineral oil 1000 MG/ML 401638

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Heavy mineral oil 1000 MG/ML SCDC · 401638
  • Heavy mineral oil Oral Solution SCDF · 401639
  • Heavy mineral oil Oral Liquid Product SCDG · 1160305
  • Heavy mineral oil Oral Product SCDG · 1160306

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 311714 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00395-1685-28 3800 mL in 1 BOTTLE, PLASTIC (0395-1685-28) Humco Mineral Oil Heavy Humco Holding Group, Inc. 2017-11-14
82645-0906-16 473 mL in 1 BOTTLE, PLASTIC (82645-906-16) Mineral Oil Heavy Pharma Nobis, LLC 2018-12-18
82645-0906-32 950 mL in 1 BOTTLE, PLASTIC (82645-906-32) Mineral Oil Heavy Pharma Nobis, LLC 2020-01-31
Observed labelers: Pharma Nobis, LLC (2) · Humco Holding Group, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.